MMV: Invest in impact

MMV: Invest in impact

Malaria is preventable and treatable, yet it still takes lives every day. Since 1999, MMV-supported medicines have helped treat or protect more than 1 billion people. That is real progress. But the fight is changing. Drug resistance is rising. Climate pressures, fragile health systems and funding challenges are making malaria harder to control and eliminate. To stay ahead, the next generation of tools must be simpler to deliver and use in real-world settings. Single-dose cures and long-acting prevention approaches have the potential to make treatment easier to complete and protection easier to sustain. Every $1 invested in MMV-supported malaria medicines delivers an estimated $13 in health benefits. This World Malaria Day, the focus is clear: protect progress and invest in what comes next.